Literature DB >> 3525057

Twice-daily mixed regular and NPH insulin injections with new jet injector versus conventional syringes: pharmacokinetics of insulin absorption.

J P Hallé, J Lambert, I Lindmayer, K Menassa, F Coutu, A Moghrabi, L Legendre, C Legault, G Lalumière.   

Abstract

The purpose of the present study was to evaluate the feasibility of using a jet injector in a split and mixed regular and NPH insulin regimen and to compare serum glucose and free-insulin profiles obtained with the injector and the conventional syringe and needle. Twelve insulin-dependent diabetic patients were hospitalized for 5 days. After a stabilization day, six patients received their insulin injection with the injector for 2 days and with the syringe and needle for the following 2 days; the regimen was reversed for the other six patients. Diet, exercise, and insulin dosage remained constant. The serum glucose levels with the injector were consistently lower than those obtained with the syringe at all times of the day except at 5:00 a.m. and 7:30 a.m., when mean values were similar for both treatments. Free-insulin levels were higher with the injector from 10:30 a.m. to 4:30 p.m. These findings suggest that insulin absorption is faster and possibly greater with the injector than with the syringe. When switching from a syringe to an injector insulin program, insulin dose adjustment may be necessary.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3525057     DOI: 10.2337/diacare.9.3.279

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  6 in total

1.  Transdermal drug delivery by jet injectors: energetics of jet formation and penetration.

Authors:  Joy Schramm; Samir Mitragotri
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

2.  Growth hormone treatment without a needle using the Preci-Jet 50 transjector.

Authors:  P Bareille; M MacSwiney; A Albanese; C De Vile; R Stanhope
Journal:  Arch Dis Child       Date:  1997-01       Impact factor: 3.791

3.  Delivery of intracavernosal therapies using needle-free injection devices.

Authors:  D O'Kane; L Gibson; J du Plessis; A Davidson; D Bolton; N Lawrentschuk
Journal:  Int J Impot Res       Date:  2017-07-27       Impact factor: 2.896

4.  Risks of jet injection of insulin in children.

Authors:  G E Theintz; P C Sizonenko
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

5.  Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology.

Authors:  Elsemiek E C Engwerda; Evertine J Abbink; Cees J Tack; Bastiaan E de Galan
Journal:  Diabetes Care       Date:  2011-06-29       Impact factor: 19.112

6.  Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study.

Authors:  Carlos Casasnovas; Montserrat Ruiz; Aurora Pujol; Agatha Schlüter; Alba Naudí; Stéphane Fourcade; Misericordia Veciana; Sara Castañer; Antonia Albertí; Nuria Bargalló; Maria Johnson; Gerald V Raymond; Ali Fatemi; Ann B Moser; Francesc Villarroya; Manuel Portero-Otín; Rafael Artuch; Reinald Pamplona
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.